Suppliers / Annora Pharma

Annora Pharma

India 593 employees Updated 9 July 2026

Annora Pharma is a finished-dose manufacturer based in India. It appears in 85 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, JFDA (JO) and INVIMA (CO). Its GMP standing is certified by ANVISA (Brazil), EAEU_EEC and NAFDAC (NG), among 6 authorities. Its most recent recorded inspection, by US FDA, closed on 28 March 2025 as VAI. Customs aggregates show $169.8M of exports covering 2,741 molecules to 23 destinations in 2025.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
85
filings across 11 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 28 March 2025 VAI US FDA
  • 13 March 2025 NAI US FDA
  • 13 September 2019 NAI US FDA
  • 10 November 2018 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
TELANGANA, India Not on file
Sangareddy, India 3013944676
Hyderabad, India Not on file
TELANGANA STATE, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 21 1
JFDA (JO) 17 None
INVIMA (CO) 16 None
ARCSA (EC) 9 None
NCELS (KZ) 6 1
MINSA (CR) 5 None
ANVISA (Brazil) None 4
EAEU_EEC None 3
NAFDAC (NG) None 2
EMA None 1

Scale

Year Revenue Exports Destinations
2025 Not reported $169.8M 23
2024 Not reported $166.4M 14
2023 Not reported $149.3M 7
2022 Not reported $97.5M 10

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Annora Pharma

Does Annora Pharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Annora Pharma. It does have 85 filings with 11 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Annora Pharma FDA-registered?
One site operated by Annora Pharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Annora Pharma's last inspection go?
The most recent inspection on record closed on 28 March 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Annora Pharma manufacture?
4 registered sites are on record, in India and Nigeria (Telangana, Sangareddy and Hyderabad among others). Every site is listed on this page with the register it came from.
Which regulators recognise Annora Pharma's GMP?
Current GMP certificates are on record from ANVISA (Brazil), EEC (Eurasian Economic Union), NAFDAC (NG), EMA, US FDA and 1 more. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Annora Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 32 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 28 March 2025.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts